VTCN1 (Gene)

Organism:

Homo sapiens

Synonyms:B7-H4, B7H4, B7S1, B7X, B7h.5, ENTREZ:79679, HGNC:28873, MIM:608162, NM_001253849, NM_001253850, NM_024626, NP_001240778, NP_001240779, NP_078902, NR_045603, NR_045604, PRO1291, V-set domain containing T cell activation inhibitor 1, VCTN1, VTCN1, XM_011542143, XM_017002335, XP_011540445, XP_016857824

Omim:OMIM:608162

Id:0277405b-fa55-5b92-8dc4-46d236f64d8c

Hgnc:HGNC:28873

Entrez:79679

Ensembl:ENSG00000134258

Description:V-set domain containing T cell activation inhibitor 1

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View VTCN1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with VTCN1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using VTCN1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for VTCN1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with VTCN1.

Results found

Linked to

	Label	Description
	GSE252944 AKT inhibition 7 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 13 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE204836 PP-3 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115542 digoxin 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE80802 EGFR inhibition Tankyrases 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217452 docetaxel 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 13 V 11 TALAZOPARIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 9 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 13 v 11 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE204836 PP-3 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115542 digoxin 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE80802 EGFR inhibition Tankyrases 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE199107 tryptophan 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE217452 docetaxel 3 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434,GSE202438 13 V 11 TALAZOPARIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.